Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5612201
SERIAL NO

08299849

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to nucleic acid molecules which are useful in determining expression of the family of molecules known as the MAGE tumor rejection antigen precursors. These nucleic acid are molecules useful as diagnostic aids for determining whether or not an individual has cancer. Methods using these molecules are also described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LUDWIG INSTITUTE FOR CANCER RESEARCH605 THIRD AVENUE 33RD FLOOR NEW YORK NEW YORK 10158 UNITED STATES OF AMERICA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boon-Falleur, Thierry Brussels, BE 156 1105
Chomez, Patrick Brussels, BE 9 269
De, Plaen Etienne Brussels, BE 26 551
De, Smet Charles Brussels, BE 15 124
Lethe, Bernard Brussels, BE 16 172
Szikora, Jean-Pierre Brussels, BE 2 89

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation